These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2996729

  • 21. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M, Harpey C, Allal J, Sellier P, Ourbak P.
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [Abstract] [Full Text] [Related]

  • 22. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M, Mérillon JP, Guiomard A, Eustigneff T, Zannier D, Gourgon R.
    Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
    [Abstract] [Full Text] [Related]

  • 23. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R.
    Z Kardiol; 1984 Jun; 73 Suppl 2():79-88. PubMed ID: 6528705
    [Abstract] [Full Text] [Related]

  • 24. [Haemodynamic effects of nefopam (author's transl)].
    Hagemann K, Platte G, Meyer J, Effert S.
    Dtsch Med Wochenschr; 1978 Jun 23; 103(25):1040-3. PubMed ID: 668511
    [Abstract] [Full Text] [Related]

  • 25. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
    Condorelli M, Brevetti G, Chiariello M, Miceli D, Lavecchia G, Paudice G, Verrienti S.
    Br J Clin Pharmacol; 1982 Jun 23; 13(1 Suppl):101S-110S. PubMed ID: 7093092
    [Abstract] [Full Text] [Related]

  • 26. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF, White DA.
    S Afr Med J; 1983 Jan 15; 63(3):67-71. PubMed ID: 6849167
    [Abstract] [Full Text] [Related]

  • 27. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE, Hill JA, Feldman RL.
    Am J Cardiol; 1987 May 01; 59(12):1084-8. PubMed ID: 2883869
    [Abstract] [Full Text] [Related]

  • 28. Alpha- and beta-blockade in angina pectoris.
    Taylor SH.
    Drugs; 1984 May 01; 28 Suppl 2():69-87. PubMed ID: 6151892
    [Abstract] [Full Text] [Related]

  • 29. Evidence for improved cardiac performance after beta-blockade in patients with coronary artery disease.
    Reale A, Nigri A, Gioffrè PA.
    J Int Med Res; 1976 May 01; 4(5):338-46. PubMed ID: 18374
    [Abstract] [Full Text] [Related]

  • 30. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Feldman RL, Prida XE, Lambert CR, Hill JA.
    Cardiovasc Drugs Ther; 1988 Sep 01; 2(3):355-61. PubMed ID: 3155428
    [Abstract] [Full Text] [Related]

  • 31. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
    Sladen RN, Klamerus KJ, Swafford MW, Prough DS, Mann HJ, Leslie JB, Goldberg JS, Levitsky S, Molina JE, Mills SA.
    J Cardiothorac Anesth; 1990 Apr 01; 4(2):210-21. PubMed ID: 2131869
    [Abstract] [Full Text] [Related]

  • 32. Labetalol in the treatment of angina pectoris.
    Kanto JH.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar 01; 25(3):166-74. PubMed ID: 2881899
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Comparative measurement of pulmonary artery pressure after meproscillarin and beta-methyldigoxin demonstrating their effects on the left bentricular function in patients with heart and coronary insufficiency].
    Stauch M, Nissen N, Grewe N.
    Arzneimittelforschung; 1978 Mar 01; 28(3a):545-50. PubMed ID: 580586
    [No Abstract] [Full Text] [Related]

  • 37. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
    Frishman WH.
    Cardiovasc Drugs Ther; 1988 Sep 01; 2(3):343-53. PubMed ID: 2908732
    [Abstract] [Full Text] [Related]

  • 38. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
    Halprin S, Frishman W, Kirschner M, Strom J.
    Am Heart J; 1980 Mar 01; 99(3):388-96. PubMed ID: 7355700
    [No Abstract] [Full Text] [Related]

  • 39. Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.
    Hartling OJ, Svendsen TL, Trap-Jensen J.
    Eur J Clin Invest; 1980 Dec 01; 10(6):431-5. PubMed ID: 6265221
    [Abstract] [Full Text] [Related]

  • 40. Labetalol binding to specific alpha- and beta-adrenergic sites in vitro and its antagonism of adrenergic responses in vivo.
    Greenslade FC, Tobia AJ, Madison SM, Krider KM, Newquist KL.
    J Mol Cell Cardiol; 1979 Aug 01; 11(8):803-11. PubMed ID: 226721
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.